REQUEST A DEMO
Total
USD $0.00
Search more companies

Pharmavene Sp. z o.o. (Poland)

Main Activities: All Other Food Manufacturing
Secondary Activities: Pharmaceutical Preparation Manufacturing | Chemical and Allied Products Merchant Wholesalers | Miscellaneous Nondurable Goods Merchant Wholesalers | Other Depository Credit Intermediation | Other Activities Related to Credit Intermediation | Lessors of Real Estate | Real Estate Property Managers | Credit Bureaus
Full name: Pharmavene Sp. z o.o. Profile Updated: October 24, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Polish Download a sample report

Pharmavene Sp. z o.o. is an enterprise in Poland, with the main office in Skarbka Dolna. It operates in the All Other Food Manufacturing industry. The company was established on July 15, 2019. The latest financial highlights indicate a net sales revenue increase of 81.77% in 2022. There was a total negative growth of 14.47% in Pharmavene Sp. z o.o.’s total assets over the same period. In 2022, Pharmavene Sp. z o.o.’s net profit margin increased by 19.02%.

Headquarters
Skarbka Dolna 42
Skarbka Dolna; Swietokrzyskie; Postal Code: 27-423

Contact Details: Purchase the Pharmavene Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Pharmavene Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Pharmavene Sp. z o.o. report to view the information.
Incorporation Date:
July 15, 2019
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Management Board Member
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Pharmavene Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
81.77%
Total operating revenue
98.73%
Operating profit (EBIT)
217.01%
EBITDA
213.26%
Net Profit (Loss) for the Period
218.68%
Total assets
-14.47%
Total equity
134.44%
Operating Profit Margin (ROS)
20.84%
Net Profit Margin
19.02%
Return on Equity (ROE)
14.9%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?